Clinical significance of preoperative lymphoscintigraphy for sentinel lymph node biopsy in breast cancer

被引:18
作者
Ogasawara, Yutaka [1 ]
Yoshitomi, Seiji [1 ]
Sato, Shuhei [2 ]
Doihara, Hiroyoshi [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Canc & Thorac Surg, Okayama 7008558, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Radiol, Okayama 7008558, Japan
关键词
breast cancer; sentinel lymph node biopsy; lymphoscintigraphy;
D O I
10.1016/j.jss.2007.10.022
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Lymphoscintigraphy (LSG) has been widely used as an additional modality to sentinel lymph node biopsy (SLNB) using isotope. However, the significance of the number of LSG-visualized axillary nodes has not been fully understood. We analyzed this and discussed its potential as a modality to complement SLNB. Methods. Ninety-one breasts and axillary lymph nodal status were evaluated retrospectively. All patients were examined by LSG using isotope and subsequently by SLNB. Results. Nine patients (9.9%) had no LSG-visualized axillary node, while 61 patients (67.0%) had only 1 node, and 21 patients (23.1%) had multiple nodes. Overall, sentinel lymph node (SLN) identification rate was 96.7%, and the mean number of removed SLNs was 1.5 nodes per patient. In patients with nonvisualized nodes, 66.7% of SLNs were successfully identified, while 100% of SLNs were identified in those with LSG-visualized nodes. Compared with patients with less than one visualized node, significantly more SLNs were removed in patients with multiple visualized nodes. The number of LSG-visualized nodes correlated with that of metastatic nodes. Conclusions. Preoperative LSG is effective in evaluating SLN status, and the LSG status could be associated with the number of dissected SLN. Moreover, the results of LSG potentially reflect the histological nodal status. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:191 / 196
页数:6
相关论文
共 28 条
[1]   Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers [J].
Alazraki, NP ;
Eshima, D ;
Eshima, LA ;
Herda, SC ;
Murray, DR ;
Vansant, JP ;
Taylor, AT .
SEMINARS IN NUCLEAR MEDICINE, 1997, 27 (01) :55-67
[2]   Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma detecting probe [J].
Alazraki, NP ;
Styblo, T ;
Grant, SF ;
Cohen, C ;
Larsen, T ;
Waldrop, S ;
Aarsvold, JN .
RADIOLOGIC CLINICS OF NORTH AMERICA, 2001, 39 (05) :947-+
[3]   Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma-detecting probe [J].
Alazraki, NP ;
Styblo, T ;
Grant, SF ;
Cohen, C ;
Larsen, T ;
Aarsvold, JN .
SEMINARS IN NUCLEAR MEDICINE, 2000, 30 (01) :56-64
[4]   Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [J].
Albertini, JJ ;
Lyman, GH ;
Cox, C ;
Yeatman, T ;
Balducci, L ;
Ku, NN ;
Shivers, S ;
Berman, C ;
Wells, K ;
Rapaport, D ;
Shons, A ;
Horton, J ;
Greenberg, H ;
Nicosia, S ;
Clark, R ;
Cantor, A ;
Reintgen, DS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22) :1818-1822
[5]   Sentinel node biopsy in breast cancer [J].
Barnwell, JM ;
Arredondo, MA ;
Kollmorgen, D ;
Gibbs, JF ;
Lamonica, D ;
Carson, W ;
Zhang, P ;
Winston, J ;
Edge, SB .
ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (02) :126-130
[6]   Breast cancer: Variables affecting sentinel lymph node visualization at preoperative lymphoscintigraphy [J].
Birdwell, RL ;
Smith, KL ;
Betts, BJ ;
Ikeda, DM ;
Strauss, HW ;
Jeffrey, SS .
RADIOLOGY, 2001, 220 (01) :47-53
[7]  
CABANAS RM, 1977, CANCER, V39, P456, DOI 10.1002/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO
[8]  
2-I
[9]  
CABANAS RM, 1992, UROL CLIN N AM, V19, P267
[10]   Factors of importance for scintigraphic non-visualisation of sentinel nodes in breast cancer [J].
Chakera, AH ;
Friis, E ;
Hesse, U ;
Al-Suliman, N ;
Zerahn, B ;
Hesse, B .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (03) :286-293